Stock Research for TARO


Featured Broker: Ally Invest

Get the due diligence for another stock.


TARO Stock Chart & Research Data

The TARO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TARO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


TARO Due diligence Resources & Stock Charts

The TARO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TARO Detailed Price Forecast - CNN Money CNN View TARO Detailed Summary - Google Finance
Yahoo View TARO Detailed Summary - Yahoo! Finance Zacks View TARO Stock Research & Analysis -

Stock Analysis

TradeIdeas View TARO Trends & Analysis - Trade-Ideas Barrons View TARO Major Holders - Barrons
NASDAQ View TARO Call Transcripts - NASDAQ Seeking View TARO Breaking News & Analysis - Seeking Alpha
Spotlight View TARO Annual Report - OTC Report View TARO OTC Short Report -
TradeKing View TARO Fundamentals - TradeKing Charts View TARO SEC Filings - Bar Chart
WSJ View Historical Prices for TARO - The WSJ Morningstar View Performance/Total Return for TARO - Morningstar
MarketWatch View the Analyst Estimates for TARO - MarketWatch CNBC View the Earnings History for TARO - CNBC
StockMarketWatch View the TARO Earnings - StockMarketWatch MacroAxis View TARO Buy or Sell Recommendations - MacroAxis
Bullish View the TARO Bullish Patterns - American Bulls Short Pains View TARO Short Pain Metrics -

Social Media Mentions

StockTwits View TARO Stock Mentions - StockTwits PennyStocks View TARO Stock Mentions - PennyStockTweets
Twitter View TARO Stock Mentions - Twitter Invest Hub View TARO Investment Forum News - Investor Hub
Yahoo View TARO Stock Mentions - Yahoo! Message Board Seeking Alpha View TARO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for TARO - Insider Cow View Insider Transactions for TARO - Insider Cow
CNBC View TARO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TARO - OTC Markets
Yahoo View Insider Transactions for TARO - Yahoo! Finance NASDAQ View Institutional Holdings for TARO - NASDAQ

Stock Charts

FinViz View TARO Stock Insight & Charts - StockCharts View TARO Investment Charts -
BarChart View TARO Stock Overview & Charts - BarChart Trading View View TARO User Generated Charts - Trading View

Latest Financial News for TARO

Who Owns Taro Pharmaceutical Industries Ltd (NYSE:TARO)?
Posted on Tuesday September 11, 2018

If you want to know who really controls Taro Pharmaceutical Industries Ltd (NYSE:TARO), then you’ll have to look at the makeup of its share registry. Institutions often own shares inRead More...

What Makes Taro Pharmaceutical (TARO) a Strong Sell?
Posted on Thursday September 06, 2018

Taro Pharmaceutical (TARO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Taro Pharmaceutical (TARO) Q1 Earnings and Revenues Miss Estimates
Posted on Thursday August 09, 2018

Taro (TARO) delivered earnings and revenue surprises of -26.61% and -13.88%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

Taro: Fiscal 1Q Earnings Snapshot
Posted on Thursday August 09, 2018

On a per-share basis, the Haifa Bay, Israel-based company said it had profit of $1.71. The drug maker posted revenue of $154.6 million in the period. Taro shares have risen 7 percent since the beginning ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.